Co-existing pericardial and pleural malignant mesothelioma responding well to nedaplatin and pemetrexed: a case report

BACKGROUND: Malignant mesothelioma (MM) is a rare cancer with poor prognosis. It is less common that two serosal cavities are involved when the patient seeks medical attention firstly. The current first-line chemotherapy for advanced MM is a combination with cisplatin and pemetrexed. However, nedapl...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Mindan, Li, Zhixuan, Cai, Junfu, Zhong, Xianyang, Zheng, Wenchuan, Wu, Shuhan, Lin, Maohuang, Zhang, Qichuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628414/
https://www.ncbi.nlm.nih.gov/pubmed/37942039
http://dx.doi.org/10.21037/acr-22-102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628414/
https://www.ncbi.nlm.nih.gov/pubmed/37942039
http://dx.doi.org/10.21037/acr-22-102

Ejemplares similares